Adrenal
|
October 10, 2024

Symptoms of Pheochromocytoma and When to See Your Doctor

Medically Reviewed by
Updated On
October 25, 2024

If you've been grappling with unexplained episodes of high blood pressure, rapid heart rate, or seemingly random surges of anxiety, there may be more to your story. These symptoms can be the hallmark of pheochromocytoma, a rare type of adrenal gland tumor.

While this condition affects only about 2 to 8 people per million each year, its symptoms often mimic more common disorders like anxiety, hypertension, or panic attacks, risking misdiagnosis and potentially life-threatening consequences. Recognizing pheochromocytoma symptoms is the first step toward receiving a timely diagnosis and improving patient outcomes.

[signup]

What Is Pheochromocytoma?

Pheochromocytoma is a rare tumor that develops in the adrenal glands, small organs located on top of each kidney. These glands are part of the body's endocrine system and produce hormones like adrenaline, cortisol, aldosterone, and dehydroepiandrosterone (DHEA). 

Pheochromocytomas are made of chromaffin cells, which are specialized cells within the inner part of the adrenal gland (adrenal medulla) responsible for producing catecholamines. These hormones, including epinephrine (adrenaline) and norepinephrine (noradrenaline), regulate various physiological processes, such as the stress ("fight-or-flight") response, blood pressure, and heart rate.

Paragangliomas are similar tumors made of chromaffin cells outside the adrenal glands, commonly along blood vessels and nerve pathways in the head and neck. 

Pheochromocytomas usually affect people between 30 and 50 years old. They are typically benign (non-cancerous) tumors; however, up to 10% of cases are malignant (cancerous) and can spread to other parts of the body. (31

The exact cause of pheochromocytoma is often unclear, but up to 35% of cases have a genetic link and may run in families (31). Scientists have found 20 different genes that can cause pheochromocytoma, and the incidence of pheochromocytoma is higher in people with other genetic conditions, including: 

Common Symptoms of Pheochromocytoma

Pheochromocytoma symptoms occur when the tumor secretes catecholamines and can vary widely in severity, frequency, and duration. Episodes may happen once a month to several times per day. As the tumor grows and produces increasing amounts of catecholamines, the symptoms often become more frequent and intense. (24

Emotional stress, physical exertion, dietary tyramines, and certain medications can trigger these episodes, but symptoms may also appear unexpectedly (34). 

The most common symptom of pheochromocytoma is high blood pressure (often resistant to treatment), affecting 60% of patients. A dangerous blood pressure spike over 180/120 mmHg is called a hypertensive crisis and can cause stroke, heart attack, loss of consciousness, and damage to the eyes and kidneys.  

The other cardinal symptoms of pheochromocytoma include episodic:

  • Headache
  • Sweating 
  • Rapid heartbeat (tachycardia) 
  • Tremors or shaking
  • Anxiety

Less common symptoms can include:

  • Chest pain
  • Abdominal pain
  • Nausea and vomiting
  • Diarrhea or constipation
  • Orthostatic hypotension (a drop in blood pressure with standing)
  • Unexplained weight loss
  • Pale skin
  • Hyperglycemia (high blood sugar)

When to See a Doctor

Pheochromocytoma is rare. Most people with these symptoms don't have pheochromocytoma. However, you should talk to a doctor if you have any of the following:

  • Episodic or constant high blood pressure, especially if it is resistant to treatment
  • Episodes of unexplained headaches, rapid heart rate, sweating, tremors, and anxiety
  • A family history of pheochromocytoma or paraganglioma
  • A family or personal history of a related genetic condition, such as MEN2, VHL disease, NF1, or HPPS

If your at-home blood pressure reading is 180/120 mmHg or greater, retake your blood pressure after 1-2 minutes. If the second reading is just as high, call 911 if you have any of these symptoms:

  • Chest pain
  • Shortness of breath
  • Back pain
  • Numbness
  • Muscle weakness
  • Changes in vision
  • Difficulty speaking 
  • Confusion
  • Dizziness
  • Vomiting 

Diagnostic Process

If your doctor suspects pheochromocytoma, they will start the diagnostic process by ordering a blood or urine test:

  • Plasma-Fractionated Metanephrines: This test measures the metabolites of epinephrine and norepinephrine in the blood. To reduce the risk of false-positive results, it is recommended to perform the blood draw after the patient has been lying down for at least 30 minutes. 
  • 24-Hour Urinary-Fractionated Metanephrines: This test measures the metabolites of epinephrine and norepinephrine excreted in the urine over 24 hours. Urinary creatinine should also be measured to verify the adequacy of the urine sample.

A positive test (elevated fractionated metanephrines) requires follow-up imaging to locate the tumor. An abdominal and pelvic CT scan is the recommended first-line imaging modality; MRI is an acceptable alternative if CT is contraindicated (20).

Patients who have been diagnosed with pheochromocytoma should undergo genetic testing to detect mutations that increase their risk for an inherited syndrome and other related tumors (20).

Pheochromocytoma Differential Diagnosis

Conditions with similar clinical presentations to pheochromocytoma include: 

Therefore, additional testing can be ordered to rule out these conditions and help pinpoint the exact cause of the patient's symptoms:

Other lab findings common in patients with pheochromocytoma include:

Treatment Options

Factors that help determine the best course of treatment for pheochromocytoma include the tumor's characteristics (e.g., size, location, benign vs. malignant), the presence of metastasis, genetic factors, and the patient's overall health and preferences. (45

When possible, surgery is the preferred treatment option for pheochromocytoma, with a success rate of 90%. In cases of inherited pheochromocytoma affecting one adrenal gland, your doctor will likely remove the entire adrenal gland. If both adrenal glands have pheochromocytomas, the surgeon will aim to remove the tumors while preserving as much normal adrenal tissue as possible to minimize the need for lifelong hormone replacement therapy. (30, 34

Medications will also be prescribed at diagnosis to manage pheochromocytoma symptoms before surgery. This includes:

  • Drugs that normalize blood pressure (alpha-blockers)
  • Drugs that keep heart rate regular (beta-blockers)
  • Drugs that block the excess catecholamines made by the adrenal gland

For metastatic and recurrent pheochromocytoma, your doctor may recommend other treatment options, including:

  • Radiation therapy
  • Chemotherapy
  • Ablation therapy (uses high or low temperatures to selectively kill tumor cells)
  • Embolization therapy (blocks blood flow to the tumor)
  • Targeted therapy (uses medications called tyrosine kinase inhibitors to prevent tumor growth)

Long-term Management and Follow-up

Follow-up is required postoperatively and then annually for at least ten years for patients with benign pheochromocytoma to confirm treatment success and monitor for tumor recurrence:

  • Measure plasma or urine metanephrine levels
  • Additional testing is also recommended annually for patients with RET gene mutations, including serum calcitonin and calcium.

In addition to annual laboratory testing, patients at high risk for recurrence should have repeat imaging scheduled at regular intervals: 

  • Every 3-4 months for the first year
  • Every 4-6 months during the second year
  • Every 6-12 months until ten years
  • Every 24-48 months after ten years

Complications of Untreated Pheochromocytoma

While the prognosis of pheochromocytoma is good, untreated tumors can lead to potentially serious and life-threatening complications.

An adrenergic crisis is characterized by a sudden surge of catecholamines, causing intense symptoms such as severe hypertension and arrhythmias that can cause heart attack or stroke, in addition to damage to the eyes and kidneys. 

Other complications of untreated pheochromocytoma include:

  • Cardiomyopathy (disease of the heart muscle)
  • Myocarditis (inflammation of the heart muscle)
  • Cerebral hemorrhage (bleeding in the brain)
  • Pulmonary edema (fluid accumulation in the lungs)

Rarely, a pheochromocytoma is cancerous and can metastasize (travel) to other parts of the body, such as the lymphatic system, bones, liver, or lungs. 

[signup]

Key Takeaways

  • Pheochromocytoma presents with hallmark symptoms such as severe headaches, excessive sweating, rapid heart rate, and hypertension, often manifesting as episodic adrenergic crises. 
  • While the majority of these tumors are benign, they can lead to life-threatening complications if left untreated, including hypertensive crises and cardiovascular disease.
  • Therefore, patients should consult their healthcare providers if they experience any of these symptoms. 
  • Additionally, healthcare professionals should maintain pheochromocytoma on their differential diagnosis when patients present with these hallmark symptoms, particularly in cases of resistant hypertension, to ensure timely diagnosis and effective management. 
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.

Learn more

No items found.

Lab Tests in This Article

No lab tests!
  1. Aygun, N. (2020). Pheochromocytoma and paraganglioma: from Epidemiology to Clinical Findings. The Medical Bulletin of Sisli Hospital, 54(2). https://doi.org/10.14744/semb.2020.18794
  2. Blake, M. A. (2024). Pheochromocytoma Workup. Medscape. https://emedicine.medscape.com/article/124059-workup#c1
  3. Carney, J. A. (2009). Carney Triad: A Syndrome Featuring Paraganglionic, Adrenocortical, and Possibly Other Endocrine Tumors. The Journal of Clinical Endocrinology & Metabolism, 94(10), 3656–3662. https://doi.org/10.1210/jc.2009-1156
  4. Carney-Stratakis syndrome. (2024, June 6). National Organization for Rare Disorders. https://rarediseases.org/mondo-disease/carney-stratakis-syndrome/
  5. Chromaffin Cell. Chromaffin Cell. https://doi.org/10.1016/b978-0-12-802393-8.00005-3
  6. Cloyd, J. (2023a, April 10). A Functional Medicine Hypertension Protocol. Rupa Health. https://www.rupahealth.com/post/functional-medicine-hypertension-protocol
  7. Cloyd, J. (2023, June 13). A Functional Medicine Menopause Protocol: Comprehensive Testing, Nutrition, and Supplements. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-menopause-protocol-comprehensive-testing-nutrition-and-supplements
  8. Cloyd, J. (2023, August 21). Thyroid Hormone Testing Guide: A Comprehensive Review of How to Test for Thyroid Hormones. Rupa Health. https://www.rupahealth.com/post/thyroid-hormone-testing-guide-a-comprehensive-review-of-how-to-test-for-thyroid-hormones
  9. Cloyd, J. (2023, October 9). Rhythms of the Heart: Demystifying Common Types of Heart Arrhythmia. Rupa Health. https://www.rupahealth.com/post/rhythms-of-the-heart-demystifying-common-types-of-heart-arrhythmia
  10. Cloyd, J. (2023, December 1). How to Interpret CBC Results: A Comprehensive Guide. Rupa Health. https://www.rupahealth.com/post/how-to-interpret-cbc-results-a-comprehensive-guide
  11. Cloyd, J. (2024, September 10). High Calcium Levels: What It Means for Your Health. Rupa Health. https://www.rupahealth.com/post/high-calcium-levels-what-it-means-for-your-health
  12. Daglis, S. (2024, August 16). High RBC Count Explained: What It Means and What to Do Next. Rupa Health. https://www.rupahealth.com/post/high-rbc-count-explained-what-it-means-and-what-to-do-next
  13. DeCesaris, L. (2023, August 16). How To Test For Female Hormones: A Comprehensive Guide. Rupa Health. https://www.rupahealth.com/post/how-to-test-for-female-hormones-a-comprehensive-guide
  14. Diorio, B. (2022, October 25). How to Balance Adrenaline Levels Naturally. Rupa Health. https://www.rupahealth.com/post/adrenaline
  15. Fassnacht, M., Assie, G., Baudin, E., et al. (2020). Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 31(11), 1476–1490. https://doi.org/10.1016/j.annonc.2020.08.2099
  16. García, M. I. D. O., Palasí, R., Gómez, R. C., et al. (2019). Surgical and Pharmacological Management of Functioning Pheochromocytoma and Paraganglioma (R. Mariani-Costantini, Ed.). PubMed; Codon Publications. https://www.ncbi.nlm.nih.gov/books/NBK543229/
  17. Garg, M. K., Kharb, S., Brar, K. S., et al. (2011). Medical management of pheochromocytoma: Role of the endocrinologist. Indian Journal of Endocrinology and Metabolism, 15(Suppl4), S329–S336. https://doi.org/10.4103/2230-8210.86976
  18. Gerow, S. (2024, May 20). Hormones (Types, Definition & Functions). Rupa Health. https://www.rupahealth.com/post/hormones-types-definition-functions
  19. Gil-Barrionuevo, E., Balibrea, J. M., Caubet, E., et al. (2018). Adrenergic cardiomyopathy and cardiogenic shock as initial presentation of pheochromocytoma. A case report and review of the literature. International Journal of Surgery Case Reports, 49, 145–148. https://doi.org/10.1016/j.ijscr.2018.06.024
  20. Gupta, P. K., & Marwaha, B. (2023, March 5). Pheochromocytoma. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK589700/
  21. Hannah-Shmouni, F., Pacak, K., & Stratakis, C. A. (2017). Metanephrines for Evaluating Palpitations and Flushing. JAMA, 318(4), 385. https://doi.org/10.1001/jama.2017.5926
  22. Henry, E. (2022, February 4). A Functional Medicine Approach to Migraines. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-migraines
  23. Hereditary Paraganglioma-Pheochromocytoma Syndromes. (2024). Memorial Sloan Kettering Cancer Center. https://www.mskcc.org/cancer-care/risk-assessment-screening/genetic-counseling-and-testing/hereditary-cancer-genes-and-hereditary-cancer-syndromes/hereditary-paraganglioma-pheochromocytoma-syndromes
  24. Johnson, J. (2019, September 3). What's to know about pheochromocytoma? Medical News Today. https://www.medicalnewstoday.com/articles/318203#symptoms
  25. Kresge, K. (2023, March 21). An Integrative Medicine Team Approach to Treating Anxiety. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-team-approach-to-treating-anxiety
  26. Kresge, K. (2023, April 7). An Integrative Medicine Approach to Panic Attacks. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-panic-attacks
  27. Multiple endocrine neoplasia, type 2 (MEN 2). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/men-2/symptoms-causes/syc-20540486
  28. Neurofibromatosis type 1. (2024, September 10). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/neurofibromatosis-type-1/symptoms-causes/syc-20350490
  29. Paraganglioma. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/22394-paraganglioma
  30. Pheochromocytoma. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/23373-pheochromocytoma#symptoms-and-causes
  31. Pheochromocytoma. (2020, February 12). National Cancer Institute. https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-endocrine-tumor/pheochromocytoma
  32. Pheochromocytoma. (2020, March 3). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/pheochromocytoma/symptoms-causes/syc-20355367
  33. Pheochromocytoma and Paraganglioma. (2019). New England Journal of Medicine, 381(19), 1882–1883. https://doi.org/10.1056/nejmc1912022
  34. Pheochromocytoma and Paraganglioma Treatment (PDQ®)–Patient Version - National Cancer Institute. (2011, December 23). National Cancer Institute. https://www.cancer.gov/types/pheochromocytoma/patient/pheochromocytoma-treatment-pdq
  35. Ronen, J. A., Gavin, M., Ruppert, M. D., et al. (2019). Glycemic Disturbances in Pheochromocytoma and Paraganglioma. Cureus, 11(4). https://doi.org/10.7759/cureus.4551
  36. Sweetnich, J. (2023, February 24). The Importance of Testing DHEA Levels. Rupa Health. https://www.rupahealth.com/post/evidence-based-health-benefits-of-dhea
  37. Sweetnich, J. (2023, February 28). How to Balance Cortisol Levels Naturally. Rupa Health. https://www.rupahealth.com/post/how-to-balance-cortisol-levels-naturally
  38. Sweetnich, J. (2023, June 12). Integrative Treatment Options for Adrenal Disorders: Specialty Testing, Nutrition, Supplements. Rupa Health. https://www.rupahealth.com/post/integrative-treatment-options-for-adrenal-disorders-specialty-testing-nutrition-supplements
  39. Tingle, R. (2022, July 13). This Disorder Affects as Much as 17% of the General Population, yet It Is Commonly Misdiagnosed. Rupa Health. https://www.rupahealth.com/post/what-is-mast-cell-activation-syndrome-mcas
  40. Von Hippel-Lindau Disease (VHL). National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov/health-information/disorders/von-hippel-lindau-disease-vhl
  41. Wang, Y., Li, N., Chang, G., et al. (2009). Clinical analysis of 28 cases of misdiagnosed pheochromocytoma. International Journal of Cardiology, 137, S23–S24. https://doi.org/10.1016/j.ijcard.2009.09.077
  42. Weinberg, J. L. (2022, February 10). A Functional Medicine Approach to POTS: Postural Orthostatic Tachycardia Syndrome. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-pots
  43. Weinberg, J. L. (2023, February 7). A Functional Medicine Protocol for Hyperthyroidism. Rupa Health. https://www.rupahealth.com/post/5-functional-medicine-labs-that-can-assist-a-root-cause-treatment-for-hyperthyroidism
  44. Weinberg, J. L. (2023, February 21). 5 Lab Test To Run on Your Hypoglycemia Patients. Rupa Health. https://www.rupahealth.com/post/5-lab-test-for-your-hypoglycemia-patients
  45. Weinberg, J. L. (2024, January 25). A Functional Medicine Approach to Pheochromocytoma. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-pheochromocytoma
  46. When To Call 911 About High Blood Pressure. (2017). American Heart Association. https://www.heart.org/en/health-topics/high-blood-pressure/understanding-blood-pressure-readings/hypertensive-crisis-when-you-should-call-911-for-high-blood-pressure
  47. Yoshimura, H. (2023, March 30). The Importance of Running Comprehensive Metabolic Panel (CMP) on Your Patients. Rupa Health. https://www.rupahealth.com/post/the-importance-of-running-comprehensive-metabolic-panel-cmp-on-your-patients
  48. Yoshimura, H. (2023, June 2). Integrative Medicine Treatment Options Approach for Porphyria. Rupa Health. https://www.rupahealth.com/post/integrative-medicine-treatment-options-approach-for-porphyria
  49. Yoshimura, H. (2024, February 27). Strategies for Managing Resistant Hypertension. Rupa Health. https://www.rupahealth.com/post/strategies-for-managing-resistant-hypertension
  50. Yoshimura, H. (2024, March 11). Primary Aldosteronism: Pathophysiology, Diagnosis, and Management. Rupa Health. https://www.rupahealth.com/post/primary-aldosteronism-pathophysiology-diagnosis-and-management
Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Adrenal
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey Practitioners! Ready to become a world class gut health expert? Join Jeannie Gorman, MS, CCN, for a Free Live Class that dives into how popular diets impact the gut microbiome, the clinical dietary needs of your gut, biomarkers to test to analyze gut health, and gain a clear understanding of the Doctor’s Data GI360™ profile. Register here.